| Theme | For the Effective Eradication of Helicobactor pylori | |
|---|---|---|
| Title | Diagnosis for H.pylori Infection after Eradication Therapy | |
| Publish Date | 2001/06 | |
| Author | Yoshihiro Fukuda | Fourth Department of Internal Medicine, Hyogo College of Medicine |
| Author | Toshihiko Tomita | Fourth Department of Internal Medicine, Hyogo College of Medicine |
| Author | Noriyasu Yamamoto | Fourth Department of Internal Medicine, Hyogo College of Medicine |
| Author | Kazutoshi Hori | Fourth Department of Internal Medicine, Hyogo College of Medicine |
| Author | Takashi Sakagami | Fourth Department of Internal Medicine, Hyogo College of Medicine |
| Author | Kazutami Tamura | Fourth Department of Internal Medicine, Hyogo College of Medicine |
| Author | Takashi Simoyama | Fourth Department of Internal Medicine, Hyogo College of Medicine |
| [ Summary ] | In order to judge the efficiency of eradication therapy, examinations for H.pylori should be conducted over a four week period, after cessation of treatment. Histamine H2 antagonists and various mucosal protective drugs, which have no affective action on H.pylori, are recommended for use after eradication therapy. It is likely that the risk of the ulcer recurrence will be low if no H.pylori infection is confirmed using the urea breath test or antibody tests. | |